Long COVID immunity and imaging study
Part of Infections, Lungs & breathing clinical trials.
This trial studies people who had COVID-19 to understand why some develop long-term symptoms while others recover fully. It aims to find links between the immune system and brain changes using imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had COVID-19 at least 3 months ago.
- You either have ongoing symptoms (long COVID) or you fully recovered without lasting issues.
- You do not have a history of chronic fatigue syndrome before or after COVID.
- You have no history of serious psychiatric illness.
- You were never in the ICU or on a breathing machine for COVID.
- You are covered by French social security.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
This study uses a special PET scanner to look for inflammation in the brains of people with long-COVID (ongoing symptoms after COVID-19 infection). The scan may help doctors understand what's causing long-COVID and develop better treatments.
This study looks at how long “long COVID” affects children over time. It may help doctors better understand what symptoms last and what support could improve recovery.
This trial tests a care program designed to help people who continue to have symptoms after recovering from COVID-19. It aims to prevent long-term health problems and improve well-being.
This study tests whether a drug called pembrolizumab (a type of immunotherapy) can help people with ongoing neurological symptoms after COVID-19. The goal is to see if it is safe and possibly improves symptoms like brain fog, fatigue, and dizziness.
This study tests an educational program for general practitioners to improve care for patients with long COVID. It may help if you have had symptoms lasting four weeks or more after COVID-19.
Hear when a new COVID Long-Haul trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.